Calcium and vitamin D supplementation and/or periodontal therapy in the treatment of periodontitis among Brazilian pregnant women: protocol of a feasibility randomised controlled trial (the IMPROVE trial)

Paula Guedes Cocate, Gilberto Kac, Berit L Heitmann, Paulo Nadanovsky, Maria Cláudia da Veiga Soares Carvalho, Camila Benaim, Michael Maia Schlüssel, Maria Beatriz Trindade de Castro, Nadya Helena Alves-Santos, Amanda Farnum Baptista, Michael F Holick, Rana R Mokhtar, Alessandra Raymundo Bomfim, Amanda Rodrigues Amorim Adegboye, Paula Guedes Cocate, Gilberto Kac, Berit L Heitmann, Paulo Nadanovsky, Maria Cláudia da Veiga Soares Carvalho, Camila Benaim, Michael Maia Schlüssel, Maria Beatriz Trindade de Castro, Nadya Helena Alves-Santos, Amanda Farnum Baptista, Michael F Holick, Rana R Mokhtar, Alessandra Raymundo Bomfim, Amanda Rodrigues Amorim Adegboye

Abstract

Background: Periodontitis is a common oral inflammation, which is a risk factor for adverse pregnancy outcomes. Intakes of vitamin D and calcium are inversely associated with occurrence and progression of periodontitis. This study aims to assess the feasibility of a multi-component intervention, including provision of milk powder supplemented with calcium and vitamin D and periodontal therapy (PT), for improving maternal periodontal health and metabolic and inflammatory profiles of low-income Brazilian pregnant women with periodontitis.

Methods: The IMPROVE trial is a feasibility randomised controlled trial (RCT) with a 2 × 2 factorial design with a parallel process evaluation. Pregnant women with periodontitis, aged 18-40 years and with < 20 gestational weeks (n = 120) were recruited and randomly allocated into four groups: (1) fortified sachet (vitamin D and calcium) and powdered milk plus PT during pregnancy, (2) placebo sachet and powdered milk plus PT during pregnancy, (3) fortified sachet (vitamin D and calcium) and powdered milk plus PT after delivery and (4) placebo sachet and powdered milk plus PT after delivery. Dentists and participants are blinded to fortification. Acceptability of study design, recruitment strategy, random allocation, data collection procedures, recruitment rate, adherence and attrition rate will be evaluated. Data on serum levels of vitamin D, calcium and inflammatory biomarkers; clinical periodontal measurements; anthropometric measurements; and socio-demographic questionnaires are collected at baseline, third trimester and 6-8 weeks postpartum. Qualitative data are collected using focus group, for analysis of favourable factors and barriers related to study adherence.

Discussion: Oral health and mineral/vitamin supplementation are much overlooked in the public prenatal assistance in Brazil and of scarcity of clinical trials addressing these issues in low and middle-income countries,. To fill this gap the present study was designed to assess the feasibility of a RCT on acceptability of a multi-component intervention combining conventional periodontal treatment and consumption of milk fortified with calcium-vitamin D for improving periodontal conditions and maternal metabolic and inflammation status, among Brazilian low-income pregnant women with periodontitis. Thus, we hope that this relatively low-cost and safe multicomponent intervention can help reduce inflammation, improve maternal periodontal health and metabolic profile and consequently prevent negative gestational outcomes.

Trial registration: NCT, NCT03148483. Registered on May 11, 2017.

Keywords: Calcium; Feasibility randomised controlled trial; Milk; Periodontal therapy; Pregnant women; Vitamin D.

Conflict of interest statement

The study was presented to and approved by the director of the health centre where it is being conducted. Recruitment started after the IMPROVE trial protocol was submitted and approved by the Ethics Committee of School Maternity of the Federal University of Rio de Janeiro-Brazil on April 27, 2016 (certificate number 1.516.656). The study is being conducted according to the principles of Good Clinical Practice and the Declaration of Helsinki. Explanation of study procedures is given verbally to all participants and a written copy is provided in the patient information sheet. Study participation began after receipt of informed written consent. The trial was registered in the ClinicalTrials.gov database (NCT, NCT03148483. Registered 11 May 2017, https://ichgcp.net/clinical-trials-registry/NCT03148483) and its recruitment began on May 2017.No applicable.The authors declare that they have no competing interests.Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Figures

Fig. 1
Fig. 1
SPIRIT flow diagram of the IMPROVE feasibility trial
Fig. 2
Fig. 2
Recruitment of participants *Pregnant women with periodontitis but presenting extensive caries were excluded

References

    1. Graves DT, Oates T, Garlet GP. Review of osteoimmunology and the host response in endodontic and periodontal lesions. J Oral Microbiol. 2011;3(5304):1–15. 10.3402/jom.v3i0.5304.
    1. Moynihan P, Bradbury J. Compromised dental function and nutrition. Nutrition. 2001;17(2):177–178.
    1. Nazir MA. Prevalence of periodontal disease, its association with systemic diseases and prevention. Int J Health Sci (Qassim) 2017;11(2):72–80.
    1. González-Jaranay M, Téllez L, Roa-López A, et al. Periodontal status during pregnancy and postpartum. PLoS One. 2017;12(5):e0178234.
    1. Vogt M, Sallum AW, Cecatti JG, et al. Factors associated with the prevalence of periodontal disease in low-risk pregnant women. Reprod Health. 2012;9:3.
    1. Esteves Lima RP, Miranda Cota LO, Costa FO. Association between periodontitis and gestational diabetes mellitus: a case-control study. J Periodontol. 2013;84(9):1257–1265.
    1. Moura da Silva G, Coutinho SB, Piscoya MD, et al. Periodontitis as a risk factor for preeclampsia. J Periodontol. 2012;83(11):1388–1396.
    1. Macedo JF, Ribeiro RA, Machado FC, et al. Periodontal disease and oral health-related behavior as factors associated with preterm birth: a case-control study in South-Eastern Brazil. J Periodontal Res. 2014;49(4):458–464.
    1. Chokwiriyachit A, Dasanayake AP, Suwannarong W, et al. Periodontitis and gestational diabetes mellitus in non-smoking females. J Periodontol. 2013;84(7):857–862.
    1. Marcaccini AM, Novaes AB, Meschiari CA, et al. Circulating matrix metalloproteinase-8 (MMP-8) and MMP-9 are increased in chronic periodontal disease and decrease after non-surgical periodontal therapy. Clin Chim Acta. 2009;409(1–2):117–122.
    1. Okada H, Murakami S. Cytokine expression in periodontal health and disease. Crit Rev Oral Biol Med. 1998;9(3):248–266.
    1. Sharma A, Ramesh A, Thomas B. Evaluation of plasma C-reactive protein levels in pregnant women with and without periodontal disease: a comparative study. J Indian Soc Periodontol. 2009;13(3):145–149.
    1. Chambrone L, Guglielmetti MR, Pannuti CM, et al. Evidence grade associating periodontitis to preterm birth and/or low birth weight: I. A systematic review of prospective cohort studies. J Clin Periodontol. 2011;38(9):795–808.
    1. Matevosyan NR. Periodontal disease and perinatal outcomes. Arch Gynecol Obstet. 2011;283(4):675–686.
    1. Teshome A, Yitayeh A. Relationship between periodontal disease and preterm low birth weight: systematic review. Pan Afr Med J. 2016;24:215.
    1. Katz J, Lee AC, Kozuki N, et al. Mortality risk in preterm and small-for-gestational-age infants in low-income and middle-income countries: a pooled country analysis. Lancet. 2013;382(9890):417–425.
    1. Han YW. Oral health and adverse pregnancy outcomes - what's next? J Dent Res. 2011;90(3):289–293.
    1. Saini R, Saini S, Saini SR. Periodontitis: a risk for delivery of premature labor and low-birth-weight infants. J Nat Sci Biol Med. 2010;1(1):40–42.
    1. Asikainen S, Chen C, Alaluusua S, et al. Can one acquire periodontal bacteria and periodontitis from a family member? J Am Dent Assoc. 1997;128(9):1263–1271.
    1. Offenbacher S, Beck JD, Jared HL, et al. Effects of periodontal therapy on rate of preterm delivery: a randomized controlled trial. Obstet Gynecol. 2009;114(3):551–559.
    1. Sant'Ana AC, Campos MR, Passanezi SC, et al. Periodontal treatment during pregnancy decreases the rate of adverse pregnancy outcome: a controlled clinical trial. J Appl Oral Sci. 2011;19(2):130–136.
    1. Michalowicz BS, Hodges JS, DiAngelis AJ, et al. Treatment of periodontal disease and the risk of preterm birth. N Engl J Med. 2006;355(18):1885–1894.
    1. Iheozor-Ejiofor Z, Middleton P, Esposito M, et al. Treating periodontal disease for preventing adverse birth outcomes in pregnant women. Cochrane Database Syst Rev. 2017;6:CD005297.
    1. Xiong X, Buekens P, Goldenberg RL, et al. Optimal timing of periodontal disease treatment for prevention of adverse pregnancy outcomes: before or during pregnancy? Am J Obstet Gynecol. 2011;205(2):111.
    1. Anand N, Chandrasekaran SC, Rajput NS. Vitamin D and periodontal health: current concepts. J Indian Soc Periodontol. 2013;17(3):302–308.
    1. Krall EA, Wehler C, Garcia RI, et al. Calcium and vitamin D supplements reduce tooth loss in the elderly. Am J Med. 2001;111(6):452–456.
    1. Asemi Z, Samimi M, Siavashani MA, et al. Calcium-vitamin D co-supplementation affects metabolic profiles, but not pregnancy outcomes, in healthy pregnant women. Int J Prev Med. 2016;7:49.
    1. Adegboye AR, Christensen LB, Holm-Pedersen P, et al. Intake of dairy products in relation to periodontitis in older Danish adults. Nutrients. 2012;4(9):1219–1229.
    1. Adegboye AR, Twetman S, Christensen LB, et al. Intake of dairy calcium and tooth loss among adult Danish men and women. Nutrition. 2012;28(7–8):779–784.
    1. Perayil J, Menon KS, Kurup S, et al. Influence of vitamin D & calcium supplementation in the management of periodontitis. J Clin Diagn Res. 2015;9(6):ZC35–ZC38.
    1. Figueiredo ACC, Cocate PG, Adegboye ARA, et al. Changes in plasma concentrations of 25-hydroxyvitamin D and 1,25-dihydroxyvitamin D during pregnancy: a Brazilian cohort. Eur J Nutr. 2018;57(3):1059–1072.
    1. Diogenes ME, Bezerra FF, Rezende EP, et al. Effect of calcium plus vitamin D supplementation during pregnancy in Brazilian adolescent mothers: a randomized, placebo-controlled trial. Am J Clin Nutr. 2013;98(1):82–91.
    1. IBGE . Pesquisa de Orçamento Familiares 2008–2009: análise do consumo alimentar pessoal no Brasil. Rio de Janeiro: IBGE; 2011.
    1. Ross AC, Institute of Medicine (U.S.) Committee to review dietary reference intakes for vitamin D and calcium. Dietary reference intakes: calcium vitamin D. Washington, D.C: National Academies Press; 2011. p. 1115.
    1. Nedel WL, Silveira FD. Different research designs and their characteristics in intensive care. Rev Bras Ter Intensiva. 2016;28(3):256–260.
    1. Bertolazi AN, Fagondes SC, Hoff LS, et al. Validation of the Brazilian Portuguese version of the Pittsburgh Sleep Quality Index. Sleep Med. 2011;12(1):70–75.
    1. Silva FT, Araujo Júnior E, Santana EF, et al. Translation and cross-cultural adaptation of the Pregnancy Physical Activity Questionnaire (PPAQ) to the Brazilian population. Ceska Gynekol. 2015;80(4):290–298.
    1. Barbieri P, Nishimura RY, Crivellenti LC, et al. Relative validation of a quantitative FFQ for use in Brazilian pregnant women. Public Health Nutr. 2013;16(8):1419–1426.
    1. Santos IS, Matijasevich A, Tavares BF, et al. Validation of the Edinburgh Postnatal Depression Scale (EPDS) in a sample of mothers from the 2004 Pelotas Birth Cohort Study. Cad Saude Publica. 2007;23(11):2577–2588.
    1. Damasio BF, Machado WL, Silva JP. Estrutura fatorial do Questionário de Saúde Geral (QSG-12) em uma amostra de professores escolares. Aval psicol. 2011;10(1):99–105.
    1. Griep RH, Chor D, Faerstein E, et al. Construct validity of the Medical Outcomes Study's social support scale adapted to Portuguese in the Pró-Saúde Study. Cad Saude Publica. 2005;21(3):703–714.
    1. Oliveira BH, Nadanovsky P. Psychometric properties of the Brazilian version of the Oral Health Impact Profile-short form. Community Dent Oral Epidemiol. 2005;33(4):307–314.
    1. Instituto Brasileiro de Geografia e Estatística. Diretoria de Pesquisas, Coordenação de População e Indicadores Sociais, Estimativas da população residente com data de referência 1º de julho de 2017; 2017.
    1. Diagnóstico Situacional do Município de Duque de Caxias: Departamento Geral de Segurança Alimentar e Nutricional Sustentável. DESANS; 2012.
    1. de Bem LJ, Sichieri R, Burlandy L, et al. Changes in food consumption among the Programa Bolsa Família participant families in Brazil. Public Health Nutr. 2011;14(5):785–792.
    1. World Health Organization (WHO). Air quality guidelines for particulate matter, ozone, nitrogen dioxide and sulfur dioxide: Global update 2005; 2006.
    1. Freitas C, Junger W, Leon A. Air pollution in Brazilian cities: selecting health impact indicators for surveillance. Epidemiol Serv Saúde. 2013;22(3):445–54.
    1. CAPOLAC ® – A milk mineral concentrate high in milk calcium. Arla Foods Ingredients. 2018:[1-8 pp]. Available from: .
    1. Batista RM, Rosetti EP, Zandonade E, et al. Evaluation of the effect of partial examination protocols in the extent of periodontal disease. Braz J Periodontol. 2011;21(3):57–66.
    1. Yeung C. Book review: Oral health surveys: Basic methods, 5th edition. 2014. p. 333.
    1. Trad LAB. Focal groups: concepts, procedures and reflections based on practical experiences of research works in the health area. Rev Saúde Col. 2009;19(3):777–96.
    1. Kitzinger J. Focus groups with users and providers of health care. In: Pope C, Mays N, editors. Qualitative research in health care. 2. London: BMJ Books; 2000.
    1. Bardin L. Análise de conteúdo. 4a ed. Lisboa: Edições 70; 2010.
    1. Julious SA. Sample size of 12 per group rule of thumb for a pilot study. Pharm Stat. 2005;4(4):287–291.
    1. Teare MD, Dimairo M, Shephard N, et al. Sample size requirements to estimate key design parameters from external pilot randomised controlled trials: a simulation study. Trials. 2014;15(1):264.
    1. Dror DK, Allen LH. Vitamin D inadequacy in pregnancy: biology, outcomes, and interventions. Nutr Rev. 2010;68(8):465–477.
    1. Rodda CP, Benson JE, Vincent AJ, et al. Maternal vitamin D supplementation during pregnancy prevents vitamin D deficiency in the newborn: an open-label randomized controlled trial. Clin Endocrinol. 2015;83(3):363–368.
    1. Dawodu A, Saadi HF, Bekdache G, et al. Randomized controlled trial (RCT) of vitamin D supplementation in pregnancy in a population with endemic vitamin D deficiency. J Clin Endocrinol Metab. 2013;98(6):2337–2346.
    1. Hollis BW, Johnson D, Hulsey TC, et al. Vitamin D supplementation during pregnancy: double-blind, randomized clinical trial of safety and effectiveness. J Bone Miner Res. 2011;26(10):2341–2357.
    1. De-Regil LM, Palacios C, Ansary A, et al. Vitamin D supplementation for women during pregnancy. Cochrane Database Syst Rev. 2012;2:CD008873.
    1. Michalowicz BS, DiAngelis AJ, Novak MJ, et al. Examining the safety of dental treatment in pregnant women. J Am Dent Assoc. 2008;139(6):685–695.
    1. Schulz KF, Altman DG, Moher D, Group C CONSORT 2010 statement: updated guidelines for reporting parallel group randomized trials. Obstet Gynecol. 2010;115(5):1063–1070.
    1. Boutron I, Moher D, Altman DG, et al. Extending the CONSORT statement to randomized trials of nonpharmacologic treatment: explanation and elaboration. Ann Intern Med. 2008;148(4):295–309.
    1. Zwarenstein M, Treweek S, Gagnier JJ, et al. Improving the reporting of pragmatic trials: an extension of the CONSORT statement. BMJ. 2008;337:a2390.
    1. Hoffmann TC, Glasziou PP, Boutron I, et al. Better reporting of interventions: template for intervention description and replication (TIDieR) checklist and guide. BMJ. 2014;348(g1687):1–12. 10.1136/bmj.g1687.
    1. Brantsæter AL, Olafsdottir AS, Forsum E, Olsen SF, Thorsdottir I. Does milk and dairy consumption during pregnancy influence fetal growth and infant birthweight? Asystematic literature review. Food Nutr Res. 2012;56. 10.3402/fnr.v56i0.20050.

Source: PubMed

3
S'abonner